Neuromuscular blocking agents: New insights and old controversies

Seminars in Anesthesia Perioperative Medicine and Pain

Volumn 21, Issue 2, 2002, Pages 75-85

  Kopman, Aaron F ^a  

^a ST VINCENT S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ATRACURIUM; CISATRACURIUM; EDROPHONIUM; ETHER; GALLAMINE; HALOTHANE; METHOXYFLURANE; MIVACURIUM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; RAPACURONIUM BROMIDE; ROCURONIUM; SUXAMETHONIUM; TUBOCURARINE CHLORIDE; VECURONIUM;

ANESTHETIC RECOVERY; FUNCTIONAL ASSESSMENT; GRIP STRENGTH; HUMAN; MASSETER MUSCLE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; REVIEW; VISION;

EID: 0036347697     PISSN: 02770326     EISSN: None     Source Type: Journal    
DOI: 10.1053/sane.2002.34126     Document Type: Article

References (48)

1. Stimulus frequency in the detection of neuromuscular block in man
2. Quantitative assessment of residual antidepolarizing block
3. Evaluation of recovery from non-depolarizing neuromuscular blockade using a digital neuromuscular analyser: Preliminary report
4. The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans
5. Correlation of the train-of-four fade ratio with clinical signs and symptoms of residual curarization in awake volunteers
6. Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants
7. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans
8. Tactile and visual evaluation of the response to train-of-four stimulation
9. Train-of-four quantitation of competitive neuromuscular block
10. Tactile evaluation of train-of-four count as an indicator of reliability of antagonism from vecuronium or atracurium-induced neuromuscular blockade
11. The accelograph: A new neuromuscular transmission monitor
12. The TOF-Guard neuromuscular monitor. A comparison with the Myograph 2000
13. Monitoring neuromuscular block by acceleromyography: Comparison of the Mini-Accelograph with the Myograph 2000
14. Residual curarization in the recovery room
15. Residual curarization: A comparitive study of atracurium and pancuronium
16. Postoperative neuromuscular function
17. Postoperative neuromuscular blockade: A comparison between atracurium, vecuronium, and pancuronium
18. Residual curarization in the recovery room after vecuronium
19. Postoperative residual block after intermediate-acting neuromuscular blocking drugs
20. Recovery from neuromuscular blockade: Residual curarisation following atracurium or vecuronium by bolus dosing or infusions
21. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases
22. The successful implementation of pharmaceutical practice guidelines. Analysis of associated outcomes and cost savings
23. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium
24. Anesthetic practice and postoperative pulmonary complications
25. Surrogate end points: Are they meaningful?
26. The effect of d-tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans
27. Effects of partial paralysis on the swallowing reflex in conscious humans
28. Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme
29. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade?
30. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children
31. Time course of action of endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant: A comparison with succinylcholine
32. Early reversal of rapacuronium with neostigmine
33. Antagonism of rapacuronium using edrophonium or neostigmine: Pharmacodynamics and pharmacokinetics
34. Facilitation of rapid endotracheal intubations with divided doses of nondepolarizing neuromuscular blocking drugs
35. Rapid tracheal intubation with vecuronium: The priming principle
36. The priming saga: Where do we stand now?
37. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia
38. The effect of different priming doses on the pharmacodynamics of cisatracurium
39. Precurarization and priming: A theoretical analysis of safety and timing
40. Pretreatment with nondepolarizing muscle relaxants: The influence on neuromuscular transmission and pulmonary function
41. Precurarization with vecuronium and pancuronium in awake, healthy volunteers: The influence on neuromuscular transmission and pulmonary function
42. Stimulus frequency and dose response to d-tubocurarine in man
43. Succinylcholine: A new approach to muscular relaxation in anesthesiology
44. Succinylcholine (succinoxylcholine): Muscle relaxant of short duration
45. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine
46. Hemoglobin desaturation following succinylcholine-induced apnea: A study of the recovery of spontaneous ventilation in healthy volunteers
47. An alternate method for estimating the dose-response relationships of neuromuscular blocking drugs
48. Molarpotency is predictive of the speed of onset of neuromuscular block for agents of intermediate-, short-, and ultra-short duration